Bloodstream-to-eye infections are facilitated by outer blood-retinal barrier dysfunction

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Coburn, Phillip S ^a   Wiskur, Brandt J ^b   Miller, Frederick C ^a   Lagrow, Austin L ^a   Astley, Roger A ^a   Elliott, Michael H ^a,b   Callegan, Michelle C ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PROTEIN ZO1; SODIUM IODATE; COLORING AGENT; DEXTRAN; EVANS BLUE; FLUORESCEIN ISOTHIOCYANATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; IODATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL EYE INFECTION; BACTERIUM MUTANT; BLOOD RETINA BARRIER; BLOODSTREAM INFECTION; C57BL 6 MOUSE; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOPHTHALMITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; OUTER BLOOD RETINAL BARRIER DYSFUNCTION; PATHOGENESIS; PROTEIN DEPLETION; RETINA DISEASE; RETINAL PIGMENT EPITHELIUM; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ANALOGS AND DERIVATIVES; ANGIOGRAPHY; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DIABETIC RETINOPATHY; MICROBIOLOGY; PATHOLOGY; RETINA BLOOD VESSEL;

ANGIOGRAPHY; ANIMALS; BLOOD-RETINAL BARRIER; CELL SURVIVAL; CELLS, CULTURED; COLORING AGENTS; DEXTRANS; DIABETIC RETINOPATHY; ENDOPHTHALMITIS; EVANS BLUE; EYE INFECTIONS, BACTERIAL; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; IMMUNOHISTOCHEMISTRY; IODATES; KLEBSIELLA PNEUMONIAE; MALE; MICE; MICE, INBRED C57BL; RETINAL PIGMENT EPITHELIUM; RETINAL VESSELS; STAPHYLOCOCCUS AUREUS;

EID: 84991518564     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154560     Document Type: Article

References (59)

1. Enzmann V, Row BW, Yamauchi Y, Kheirandish L, Gozal D, Kaplan HJ, McCall MA. Behavioral and anatomical abnormalities in a sodium iodate-induced model of retinal pigment epithelium degeneration. Exp Eye Res. 2006; 82: 441-448. PMID: 16171805
2. Kiuchi K, Yoshizawa K, Shikata N, Moriguchi K, Tsubura A. Morphologic characteristics of retinal degeneration induced by sodium iodate in mice. Curr Eye Res. 2002; 25: 373-379. PMID: 12789545
3. Campbell M, Humphries P. The blood-retina barrier: tight junctions and barrier modulation. Adv Exp Med Biol. 2012; 763: 70-84. PMID: 23397619
4. Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol. 1991; 139: 81-100. PMID: 1713023
5. Miyamoto K, Hiroshiba N, Tsujikawa A, Ogura Y. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Opthalmol Vis Sci. 1998; 39: 2190-2194.
6. Miyamoto K, Khosrof S, Bursell S-E, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA. 1999; 96: 10836-10841. PMID: 10485912
7. Funatsu H, Yamashita H, Sakata K, Noma H, Mimura T, Suzuki M, et al. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology. 2005; 112: 806-816. PMID: 15878060
8. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R. American Diabetes Association: Diabetic retinopathy. Diabetes Care. 2003; 26: 226-229. PMID: 12502685
9. Neely KA, Gardner TW. Ocular neovascularization: clarifying complex interactions. Am J Pathol. 1998; 153: 665-670. PMID: 9736014
10. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci. 2001; 42: 2408-2413. PMID: 11527957
11. Takeda M, Mori F, Yoshida A, Takamiya A, Nakagomi S, Sato E, et al. Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats. Diabetologia. 200; 44: 1043-1050. PMID: 11484083
12. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes. 2003; 52: 506-511. PMID: 12540628
13. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin induced diabetic mice. Invest Ophthalmol Vis Sci. 2004; 45: 3330-3336. PMID: 15326158
14. Tso MO, Cunha-Vaz JG, Shih CY, Jones CW. Clinicopathologic study of blood-retinal barrier in experimental diabetes mellitus. Arch Ophthalmol. 1980; 98: 2032-2040. PMID: 7436840
15. Vinores SA, Gadegbeku C, Campochiaro PA, Green WR. Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics. Am J Pathol. 1989; 134: 231-235. PMID: 2916645
16. Weinberger D, Fink-Cohen S, Gaton DD, Priel E, Yassur Y. Non-retinovascular leakage in diabetic maculopathy. Br J Ophthalmol. 1995; 79: 728-731. PMID: 7547782
17. Xu HZ, Le YZ. Significance of outer blood-retina barrier breakdown in diabetes and ischemia.Invest Ophthalmol Vis Sci. 2011; 52: 2160-2164. doi: 10.1167/iovs.10-6518 PMID: 21178141
18. Dahrouj M, Desjardins DM, Liu Y, Crosson CE, Ablonczy Z. Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure. Exp Eye Res. 2015; 137: 50-56. doi: 10.1016/j.exer.2015.06.004 PMID: 26070987
19. Garcia-Ramírez M, Hernández C, Palomer X, Vázquez-Carrera M, Simó R. Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity. Acta Diabetol. 2016; 53: 109-118. doi: 10.1007/s00592-015-0759-3 PMID: 25936740
20. Wang S, Du S, Wu Q, Hu J, Li T. Decorin prevents retinal pigment epithelial barrier breakdown under diabetic conditions by suppressing p38 MAPK activation. Invest Ophthalmol Vis Sci. 2015; 56: 2971-2979. doi: 10.1167/iovs.14-15874 PMID: 25829413
21. Jackson TL, Paraskevopoulos T, Georgalas I. Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol. 2014; 59: 627-635. doi: 10.1016/j.survophthal.2014.06.002 PMID: 25113611
22. Ho V, Ho LY, Ranchod TM, Drenser KA, Williams GA, Garretson BR. Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis. Retina. 2011; 31: 596-601. doi: 10.1097/IAE.0b013e3181ecccf0 PMID: 21343874
23. Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013; 19: 227-234. doi: 10.1111/1469-0691.12118 PMID: 23438028
24. Arevalo J, Jap A, Chee S, Zeballos D. (2010). Endogenous endophthalmitis in the developing world. Int Ophthalmol Clin. 2010; 50: 173-187. doi: 10.1097/IIO.0b013e3181d26dfc PMID: 20375870
25. Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol. 1986; 31: 81-101. PMID: 3541265
26. Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003; 48: 403-423. PMID: 12850229
27. Okada AA, Johnson RP, Liles WC, D'Amico DJ, Baker AS. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology. 1994; 101: 832-838. PMID: 8190467
28. Coburn PS, Wiskur BJ, Christy E, Callegan MC. The diabetic ocular environment facilitates the development of endogenous bacterial endophthalmitis. Invest Ophthalmol Vis Sci. 2012; 53: 7426-7431. doi: 10.1167/iovs.12-10661 PMID: 23036996
29. Coburn PS, Wiskur BJ, Astley RA, Callegan MC. Blood-retinal barrier compromise and endogenous Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 2015; 56: 7303-7311. doi: 10.1167/iovs.15-17488 PMID: 26559476
30. Lin J, Siu L, Fung C, Tsou H, Wang J, Chen C, et al. Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control. J Clin Endocrinol Metab. 2006; 91: 3084-3087. PMID: 16720670
31. Park S, Rich J, Hanses F, Lee J. Defects in innate immunity predispose C57BL/6J-Leprdb/Leprdb mice to infection by Staphylococcus aureus. Infect Immun. 2009; 77: 1008-1014. doi: 10.1128/IAI.00976-08 PMID: 19103772
32. Wang J, Iacovelli J, Spencer C, Saint-Geniez M. Direct effect of sodium iodate on neurosensory retina. Invest Ophthalmol Vis Sci. 2014; 55: 1941-1953. doi: 10.1167/iovs.13-13075 PMID: 24481259
33. Reagan A, Gu X, Hauck SM, Ash JD, Cao G, Thompson TC, et al. Retinal Caveolin-1 Modulates Neuroprotective Signaling. Adv Exp Med Biol. 2016; 854: 411-418. doi: 10.1007/978-3-319-17121-0-54 PMID: 26427439
34. Moyer AL, Ramadan RT, Novosad BD, Astley R, Callegan MC. Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis. Invest Ophthalmol Vis Sci. 2009; 50: 3783-3793. doi: 10.1167/iovs.08-3051 PMID: 19264886
35. Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullam PM, Ramos M, Bayer AS. Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest. 1994; 94: 1815-1822. PMID: 7962526
36. Jung J, Lee J, Yu SN, Kim YK, Lee JY, Sung H, et al. Ocular involvement of Staphylococcus aureus bacteremia: incidence and risk factors. Antimicrob Agents Chemother. 2016 Jan 11. pii: AAC.02651-15. [Epub ahead of print].
37. Sheen TR, Ebrahimi CM, Hiemstra IH, Barlow SB, Peschel A, Doran KS. Penetration of the blood-brain barrier by Staphylococcus aureus: contribution of membrane-anchored lipoteichoic acid. J Mol Med (Berl). 2010; 88(6): 633-639.
38. Machalińska A, Lubiński W, Kłos P, Kawa M, Baumert B, Penkala K, et al. Sodium iodate selectively injuries the posterior pole of the retina in a dose-dependent manner: morphological and electrophysiological study. Neurochem Res. 2010; 35: 1819-1827. doi: 10.1007/s11064-010-0248-6 PMID: 20725778
39. Xia H, Krebs MP, Kaushal S, Scott EW. Enhanced retinal pigment epithelium regeneration after injury in MRL/MpJ mice. Exp Eye Res. 2011; 93: 862-872. doi: 10.1016/j.exer.2011.09.020 PMID: 21989111
40. Pitkänen L, Ranta VP, Moilanen H, Urtti A. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest Ophthalmol Vis Sci. 2005; 46: 641-646. PMID: 15671294
41. Moyer AL1, Ramadan RT, Thurman J, Burroughs A, Callegan MC. Bacillus cereus induces permeability of an in vitro blood-retina barrier. Infect Immun. 2008; 76:1358-1367. doi: 10.1128/IAI.01330-07 PMID: 18268029
42. Herbert S, Ziebandt AK, Ohlsen K, Schäfer T, Hecker M, Albrecht D, et al. Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect Immun. 2010; 78: 2877-2889. doi: 10.1128/IAI.00088-10 PMID: 20212089
43. Plata K, Rosato A, Wegrzyn G. Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicity. Acta Biochim Pol. 2009; 56:597-612. PMID: 20011685
44. Wirtz C, Witte W, Wolz C, Goerke C. Transcription of the phage-encoded Panton-Valentine leukocidin of Staphylococcus aureus is dependent on the phage life-cycle and on the host background. Microbiology. 2009; 155: 3491-3499. doi: 10.1099/mic.0.032466-0 PMID: 19661179
45. Otto M. (2010). Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol. 2010; 64: 143-162. doi: 10.1146/annurev.micro.112408.134309 PMID: 20825344
46. Löffler B, Hussain M, Grundmeier M, Brück M, Holzinger D, Varga G, et al. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog. 2010; 6: e1000715. doi: 10.1371/journal.ppat.1000715 PMID: 20072612
47. Ibberson CB, Jones CL, Singh S, Wise MC, Hart ME, Zurawski DV, et al. Staphylococcus aureus hyaluronidase is a CodY-regulated virulence factor. Infect Immun. 2014; 82: 4253-4264. doi: 10.1128/IAI.01710-14 PMID: 25069977
48. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol. 2003; 48: 1429-1449. PMID: 12791129
49. Booth MC, Cheung AL, Hatter KL, Jett BD, Callegan MC, Gilmore MS. Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun. 1997; 65: 1550-1556. PMID: 9119503
50. Booth MC, Hatter KL, Miller D, Davis J, Kowalski R, Parke DW, et al. Molecular epidemiology of Staphylococcus aureus and Enterococcus faecalis in endophthalmitis. Infect Immun. 1998; 66: 356-360. PMID: 9423880
51. Callegan M, Booth M, Jett B, Gilmore M. Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun. 1999; 67: 3348-3356. PMID: 10377112
52. Wiskur BJ, Hunt JJ, Callegan MC. Hypermucoviscosity as a virulence factor in experimental Klebsiella pneumoniae endophthalmitis. Invest Ophthalmol Vis Sci. 2008; 49: 4931-4938. doi: 10.1167/iovs.08-2276 PMID: 18586871
53. Novick R. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology. 1967; 33: 155-166. PMID: 4227577
54. Ramadan RT, Ramirez R, Novosad BD, Callegan MC. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr Eye Res. 2006; 31: 955-965. PMID: 17114121
55. Ramadan RT, Moyer AL, Callegan MC. A role for tumor necrosis factor-alpha in experimental Bacillus cereus endophthalmitis pathogenesis. Invest Ophthalmol Vis Sci. 2008; 49:4482-4489. doi: 10.1167/iovs.08-2085 PMID: 18586878
56. Bæk KT, Frees D, Renzoni A, et al. Genetic Variation in the Staphylococcus aureus 8325 Strain Lineage Revealed by Whole-Genome Sequencing. Otto M, ed. PLoS ONE. 2013; 8: e77122. doi: 10.1371/journal.pone.0077122 PMID: 24098817
57. Rasband WS, ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2014.
58. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nature Methods. 2012; 9: 671-675. PMID: 22930834
59. Abramoff MD, Magalhaes PJ, Ram SJ. Image Processing with ImageJ. Biophotonics International. 2004; 11: 36-42.